GSK Slashes Patent Protection In Lower-Income Countries
This article was originally published in Scrip
GlaxoSmithKline says it will no longer be filing for patent protection for its medicines in leastdeveloped and low-income countries. The firm is also set to be the first company ever to commit future oncology products to patent pooling.
Register for our free email digests: